According to @GoogleDeepMind, AlphaFold 2 has revolutionized protein structure prediction over the past five years, transforming a long-standing scientific challenge into a standard AI-powered tool for biological research. With more than 3 million researchers in over 190 countries leveraging AlphaFold’s predictions, the platform is now central to accelerating drug discovery, disease understanding, and biotechnology innovation. The widespread adoption of AlphaFold 2 demonstrates AI’s practical application in life sciences, offering significant business opportunities for biotech firms, pharmaceutical companies, and data-driven research organizations looking to streamline molecular modeling and reduce R&D costs (source: Google DeepMind).